Cargando…
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
Autores principales: | Wander, Seth A., Zhao, Dekuang, Besser, Alexandra H., Hong, Feng, Wei, Jianqin, Ince, Tan A., Milikowski, Clara, Bishopric, Nanette H., Minn, Andy J., Creighton, Chad J., Slingerland, Joyce M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969925/ https://www.ncbi.nlm.nih.gov/pubmed/26993130 http://dx.doi.org/10.1007/s10549-016-3752-9 |
Ejemplares similares
-
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
por: Wander, Seth A., et al.
Publicado: (2013) -
p27 transcriptionally coregulates cJun to drive programs of tumor progression
por: Yoon, Hyunho, et al.
Publicado: (2019) -
Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy
por: Sharma, Salil, et al.
Publicado: (2012) -
A Growth Tonic for Heart Failure?
por: Bishopric, Nanette H.
Publicado: (2016) -
The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells
por: Li, Shuyu, et al.
Publicado: (2013)